Background: The purpose of this study was to identify prognostic indicators of neurodevelopmental outcome in term infants who experienced clinical neonatal seizure. Methods: This is a retrospective, observational hospital-based study. Term infants who experienced clinical neonatal seizure between January 1999 and December 2009 were enrolled. Adverse outcomes were defined as death, cerebral palsy, global developmental delay, and/or epilepsy. The associations between adverse outcomes and 17 variables, including sex, mode of delivery, being small of gestational age, maternal illness, perinatal insults, meconium stained liquor, Apgar score at 1 and 5 minutes, seizure onset age, seizure type, etiology, electroencephalography (EEG) findings, antiepileptic drug efficacy, presence of metabolic acidosis, and cranial ultrasonographic findings, and presence of congenital heart disease were analyzed. Results: Among the 232 enrolled infants, 125 had a normal outcome and 14 had mild functional disability (59.9%), and 55 (23.7%) survived with one or more neurodevelopmental impairments (7 with cerebral palsy, 48 with global developmental delay), and 38 (16.4%) died. Forty-seven (23.0%) of the 204 patients who survived after the first discharge had epilepsy. Ten variables were associated with adverse outcome on univariate analysis, but only four variables, i.e., including abnormal cranial ultrasonography findings, abnormal anterior cerebral artery resistance index, abnormal EEG findings, and presence of congenital heart disease were independent predictors on multivariate logistic regression analysis. Pediatrics and Neonatology (2013) 54, 166e172 Conclusion: In term infants with neonatal seizures, several risk factors related to adverse outcome were recognized. Physicians should pay more attention to these factors when handling patients with neonatal seizures.
Introduction
Seizures are the most common and distinctive clinical manifestation of neurologic dysfunction in the newborn infants, and they may cause injury and exacerbate existing brain damage. 1, 2 The incidence of seizures is higher in the neonatal period than in any other period of life and is estimated at approximately three per 1000 live births. 1, 3 To date, the long-term neurodevelopmental outcome of children with neonatal seizures is still unclear. Early intervention for infants at risk for developmental disorders has gained wide acceptance in the last few decades due to its efficacy.
Several prognostic factors are well known, such as brain maturity (preterm vs. term), neonatal electroencephalography (EEG) background patterns, cranial ultrasonography, Apgar score, birth weight, onset of seizures or prolonged seizures. 3e6 Garfinkle et al 7 devised a 5-point scoring system in term infant seizure using variables of delivery, seizure onset age, seizure type, EEG background findings, and some etiology. Recognizing prognostic factors would be helpful for neonatal seizure patients. This retrospective study described the prognosis and searched for possible risk factors of full-term newborns with neonatal seizures.
Materials and Methods
The study population was derived from a single medical center between January 1999 and December 2009. This study was approved by the Institutional Review Boards of Mackay Memorial Hospital in Taipei, Taiwan. The medical records of all patients who were born at term (i.e., !37 weeks gestation) and had clinically evident neonatal seizures (i.e., within the first 28 days of life) were retrospectively reviewed. The diagnosis of clinical neonatal seizures was made by a pediatric neurologist and neonatologist using internationally accepted criteria. 1 All patients had at least 2 years of neurologic follow-up data, or at least 1 year if the infant was normal. Our study population consisted of 334 term infants, of whom 232 neonates (69%) met the inclusion criteria. Data collected included sex, mode of delivery, being small of gestational age, maternal illness, perinatal insults, meconium stained liquor, Apgar score at 1 and 5 minutes, seizure onset age, seizure type, etiology, EEG findings, antiepileptic drugs efficacy, presence of metabolic acidosis, cranial ultrasonography findings, and presence of congenital heart disease.
Maternal illness included hepatitis B carrier, drug abuser, vaginal group B streptococcus colonization, premature rupture of membranes, antepartum hemorrhage, placenta malfunctions, and systemic disease (i.e., hypertension, pre-eclampsia, thyroid disorders). Perinatal insults included fetal distress, delayed initial crying, need for resuscitation in labor room, prolonged labor course, abruptio placentae, cord around neck, and precipitating labor. The seizure onset age was divided to before and after 24 hours of life. Seizure types were categorized according to Volpe classification schema, 1 based on the paroxysmal clinical phenomena documented in the medical records. It included subtle, clonic, tonic, myoclonic, and mixed-type presentations.
The primary etiology of the seizure was determined through the clinical history, neuroimaging studies [computed tomography (CT), cranial ultrasonography findings, and/or magnetic resonance imaging (MRI)], and laboratory tests (cerebrospinal fluid studies, serum glucose and electrolyte levels, blood gas analysis, lactate, pyruvate, alanine transaminase, and creatine kinase). Some infants underwent Toxoplasmosis gondii, rubella, cytomegalovirus, and herpes simplex virus (TORCH) screen for congenital infection or workup for inborn error of metabolism. We divided etiology into nine groups: (1) intrapartum asphyxia, (2) metabolic disturbances (i.e., hypoglycemia, hypocalcemia, hyponatremia, hypomagnesemia), (3) infections, (4) intracranial hemorrhage, (5) cerebral infarct, (6) developmental cerebral defect, (7) inborn error of metabolism (i.e., isovaleric acidemia, tyrosinemia type 1, maple syrup urine disease), (8) miscellaneous (e.g., genetic disorder, neonatal abstinence syndrome), and (9) etiology unknown. Intrapartum asphyxia required 5-minute Apgar score of 6 and fetal distress. The diagnosis of infection (bacterial or viral) had confirmatory laboratory evidence on CSF or blood culture. Intracranial hemorrhage included epidural, subarachnoid, subdural, parenchymal, and/or intraventricular hemorrhage. In cases in which this comprehensive diagnostic evaluation revealed no etiology, infants were assigned to an "etiology unknown" category.
Interictal EEG recordings (international 10e20 system, modified) were performed in tolerated neonates (Medelec, Oxford, England). EEG analyses were performed by the neurophysiologists, with respect to background pattern and seizure activity, based on visual pattern recognition. EEG findings were grouped into two categories: (1) normal and (2) epileptiform activity or abnormal background activity.
Almost all infants had serial cranial ultrasonography examinations. Some had at least one additional modality of imaging, such as cranial CT or MRI. Cranial ultrasonography findings were grouped into two categories: (1) normal and (2) abnormal (i.e., parenchymal echodensities, hemorrhage, subependymal and choroid plexus cysts, ventricular dilatation, brain malformations). We defined normal range of anterior cerebral artery resistance index as 0.6e0.8 using the Acuson Aspen (Acuson Corp., Mountain View, CA, USA) from 1999e2005 and the Voluson 730 Pro system from 2005e2009 (GE Medical Systems, Milwaukee, WI, USA).
The drug of first choice was phenobarbital at a loading of 20e40 mg/kg and a maintenance dose of 3e8 mg/kg/day intramuscular administered. If the seizures persisted or recurred, then we administered phenytoin at a loading dose of 20 mg/kg and a maintenance dose of 4e8 mg/kg/day intravenously or midazolam loading dose of 0.1 mg/kg intravenously followed by a continuous intravenous infusion at 1e10 mg/kg/min. The presence of metabolic acidosis was defined as pH < 7.35, HCO 3 < 18 mEq/L, and need of NaHCO 3 supplement.
The neurologic outcome recorded at the last follow-up was included in the subsequent data analysis. Outcomes were defined as follows:
1. Normal and mild neurologic abnormalities (i.e., slow for age in regard to motor and/or speech, hearing impairment, mild mental retardation). 2. Cerebral palsy was defined as a static, nonprogressive motor impairment of early onset featuring objective changes in tone, muscle strength, posture, abnormal deep tendon reflexes, and motor skills on examination.
Neuromotor assessment was based on Levine clinical criteria. 8 Motor skills were compared with those expected for age. 3. Global developmental delay was defined as significant delay in two or more developmental domains: gross or fine motor, speech and language, cognition, personalsocial, and activity of daily living. 4. Epilepsy was defined as recurrent unprovoked seizures that required antiepileptic drugs. 5. We divided the above-mentioned four categories into two groups: "good outcome" (normal and mild neurological abnormalities) and "adverse outcome" (death, cerebral palsy, and global developmental delay).
Statistical analysis
Overall outcomes (i.e., good vs. adverse) were compared with regard to sex, mode of delivery, being small of gestational age, maternal illness, perinatal insults, meconium stained liquor, Apgar score at 1 and 5 minutes, seizure onset age, seizure type, etiology, EEG findings, antiepileptic drugs efficacy, presence of metabolic acidosis, cranial ultrasonography findings, and presence of congenital heart disease. Statistical analyses were performed by using SPSS 18.0 for windows (SPSS Inc, Chicago, IL, USA). We used the c 2 test and Fisher exact test for categorized data. A p value of <0.05 was considered statistical significant. Simple and multiple logistic regression models were applied to determine risk factors for adverse neurodevelopmental outcome.
Results
The retrospective cohort for analysis included 232 infants, comprising 139 males and 93 females. One hundred and thirty-three infants were born by vaginal delivery (57.3%) and 99 by cesarean delivery (42.7%). The mean birth weight was 3112.8 AE 548.6 g (1576e5020 g) and mean gestational age was 38.9 AE 1.2 weeks (37e42 weeks). Figure 1 illustrates the overlapping distribution of these adverse outcomes. The median age of death for the 10 fatalities was 26.8 AE 18.6 months (7e60 months).
Intrapartum asphyxia was the most common etiology noted and was identified in 73 children (31.5%). Second most common were metabolic disturbances diagnosed in 53 children (22.8%), followed by unknown etiology in 30 (12.9%). The most common cause of death was intrapartum asphyxia (26.0%), although 41.4% infants with intrapartum asphyxia had normal neurodevelopment. For those with known etiology, metabolic disturbances and infections had more favorable outcome (86.8%, 77.8%). Patients with unknown etiology also had a relatively favorable outcome (86.7%; Table 1 ).
Forty-seven (23.0%) of 204 patients who survived after the first discharge had epilepsy. Thirty-eight patients (80.9%) with epilepsy had adverse outcome, and nine (19.1%) patients had normal outcome. Of the 194 survivors, 35 (18.0%) received antiepileptic drugs for less than 3 months, 29 (14.9%) for 3e6 months, 34 (17.5%) for 0.5e2 years, and 36 (18.5%) for more than 2 years.
Presence of perinatal insults, Apgar score at 1 minute, time of seizure onset less 24 hours, metabolic acidosis, abnormal EEG findings, presence of congenital heart disease, abnormal cranial ultrasonography findings, and abnormal anterior cerebral artery resistance index were the most significant risk factors in univariate analysis ( Table 2 ). Other nonsignificant risk factors are not listed in Table 2 .
The 1-minute Apgar score was 3 for 39 infants (16.8%) and from 4e6 for 34 infants (14.7%). The 5-minute Apgar score was 3 for 13 infants (5.6%) and from 4e6 for 31 infants (13.4%). Only the 1-minute Apgar score was significantly associated with an adverse outcome (p < 0.001).
Time of seizure onset appeared within 24 hours in 75 infants (32.3%). Sixty-two infants (26.7%) developed seizures from 24e72 hours, 43 infants (18.5%) from 3e7 days, and 52 infants (22.4%) developed seizures after 7 days of life. Seizure type is presented in Table 1 . Subtle seizures were the most common type and constituted 44% of all seizures. This type also had a higher relationship with epilepsy (40.4%). The association of outcome and seizure type did not differ significantly. One hundred and twentyseven infants (54.7%) required phenobarbital monotherapy to achieve clinical seizure control. Additional antiepileptic drugs were administered to 91 infants (39.2%) in whom seizure control was not achieved with phenobarbital alone [phenytoin (42), benzodiazepine (10), or both (39)].
Four poor outcome predictors were found by multiple logistic regression. These were abnormal cranial ultrasonography findings, abnormal anterior cerebral artery resistance index, abnormal EEG findings, and presence of congenital heart disease (Table 3 ).
Discussion
Previous studies on neonatal seizures reported comparable percentages of surviving children with normal outcomes (35e54%), and severely abnormal outcomes (28%) to our results. 1, 4, 9 Term infants who experienced seizures are more likely to have a normal outcome than preterm infants. 4, 5, 10 Most experimental data demonstrate significant long-term adverse consequences of seizures, including permanent impairments in learning, memory, and cognition. 11, 12 EEG background findings and neuroimaging (CT/MRI) were documented as predictors in neonatal seizures of term infants, which is compatible with our results. 4, 6, 7, 13 Although some abnormalities are better detected by MRI techniques, cranial ultrasonography is sensitive enough to identify most abnormalities that are known to be associated with adverse neurologic outcome. 14, 15 Cranial ultrasonography is cost-efficient and noninvasive, and its prognostic value for later neurologic sequelae has already been suggested by several studies. 16, 17 Bolyan et al 18 found that cerebral blood flow velocity increased during neonatal seizures even during the interictal status. The increase in cerebral blood flow velocity is most likely to be due to excessive demand for glucose and oxygen, but it may still be insufficient to meet the pathological demands. A study by Archer et al 19 established a relation between abnormally low resistance index values of anterior cerebral artery and adverse neurodevelopment outcome. Prolonged excessive cerebral blood flow contributes to cerebral edema and vasoparalysis with accompanying loss of autoregulatory mechanism. 18 In our studies, abnormal anterior cerebral artery resistance index is a significantly poor prognostic factor on multivariate analysis. There was no collinearity between cranial ultrasonography and anterior cerebral artery resistance index.
Previously, the predictive values of amplitudeintegrated EEG background patterns have been demonstrated in asphyxiated infants. 20e22 Moreover, due to the absence of video-EEG monitoring, the number of infants with seizures in this cohort is probably underestimated. Background EEG abnormalities of moderate to severe grades were strong predictors of poor outcome in earlier reports. 23e26 Some also reported a correlation between multifocal EEG abnormalities and outcome. 27, 28 Monod et al 29 studied various EEG patterns in 270 mixed neonatal cohort (135 full-term babies); and they found that normal EEG was prognostic for favorable outcomes (normal or minor neurologic sequelae), and certain EEG patterns (e.g., inactive or paroxysmal EEG, low voltage with theta rhythm, persistent absence of occipital activity, abnormal anterior activity, fast spikes) were prognostically unfavorable. Abnormalities detected by brain imaging studies and number of independent electrographic seizure foci were correlated with some aspects of cognitive outcome. 30 In our study, 90 neonates (51.1%) had interictal epileptiform activity, of whom 35 had adverse outcomes and 29 had epilepsy; 13 (7.4%) had abnormal background activity, of whom 10 had adverse outcomes and seven had epilepsy. Seventeen had multifocal epileptiform activity in which 11 (64.7%) had both adverse outcomes and epilepsy. Four had a burstsuppression EEG pattern, all of whom had adverse outcomes and epilepsy. Our data showed that abnormal background and multifocal epileptiform activity were frequently related to adverse outcome and that burstsuppression EEG pattern had the worst outcome.
The infants with complex congenital heart disease are at high risk for seizures in the perioperative period. 31 It is obvious that convulsive states cause increased systemic and cerebral metabolic activities, requiring increases in energy supply. Congenital heart disease may exacerbate the energy imbalance and cause adverse outcome. It is also known that cardiac dysfunction and diminished cardiac output are late complications of seizures. 1 In our studies, presence of congenital heart disease distributes risk factors of adverse outcome.
Some studies have suggested that the cause of neonatal seizures is the most important factor in influencing outcome. 1, 4, 5, 32, 33 In particular, asphyxia and cerebral hemorrhage are related to poor outcome. Other etiologies associated with poor outcome included cerebral dysgenesis, global hypoxia-ischemia, and central nervous system infection. 4, 34 However, we did not find a statistical relationship between seizure etiology and outcome. We think that the discrepancy may be explained by the differences in study populations. Our population focused on term infants. The number of infants with metabolic disturbances was higher and intrapartum asphyxia was lower than previous studies. Heide et al 35 found that persistent seizures, despite the number of antiepileptic drugs required, are prognostic for poor outcome. Prolonged or recurrent seizures are thought to be associated with poor neurologic outcome in other studies. 30, 32, 36, 37 Recurrent neonatal seizures also result in subsequent alterations in seizure susceptibility. 38e40 Several neurobiologic changes were reported in infants with neonatal seizures, such as the disruption of neuronal development, the induction of synaptic reorganization, altered plasticity, molecular reorganization of receptors and channels, and "priming" the brain for increased damage from seizures in later life. We did not find a relation between number of antiepileptic drugs and outcome. The outcome and seizure type did not have significant association. Status epilepticus, which may be a predictor of outcome, was not recorded in our medical charts.
Conclusion
We propose four variables of term infants with neonatal seizures for providing early prognostic information on the poor neurodevelopmental outcome: abnormal cranial ultrasonography findings, abnormal anterior cerebral artery resistance index (<0.6 or >0.8), EEG epileptiform activity or abnormal background activity, and presence of congenital heart disease. 
